Regeneron Pharmaceuticals Inc (REGN)
Market Closed
2 Apr, 20:00
$
625. 60
+8.6
+1.39%
$
98.44B Market Cap
24.52 P/E Ratio
0% Div Yield
900,400 Volume
42.79 Eps
$ 617
Previous Close Day Range
610.1 628
Year Range
610.1 1,211.2
Earnings results expected in 27 days
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| REGN Regeneron Pharmaceuticals Inc 30 Apr 2025 (27 Days) | | - Cons. EPS | - EPS |
| REGN Regeneron Pharmaceuticals Inc 31 Jan 2025 | | 11.38 Cons. EPS | 12.07 EPS |
| REGN Regeneron Pharmaceuticals Inc 31 Oct 2024 | | 11.69 Cons. EPS | 12.46 EPS |
| REGN Regeneron Pharmaceuticals Inc 1 Aug 2024 | | 10.61 Cons. EPS | 11.56 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 May 2024 | | 10.09 Cons. EPS | 9.55 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 Feb 2024 | | 10.73 Cons. EPS | 11.86 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 Nov 2023 | | 10.72 Cons. EPS | 11.59 EPS |
| REGN Regeneron Pharmaceuticals Inc 4 Nov 2016 | | 2.71 Cons. EPS | 3.13 EPS |
| REGN Regeneron Pharmaceuticals Inc 4 Aug 2016 | | 2.65 Cons. EPS | 2.82 EPS |
| REGN Regeneron Pharmaceuticals Inc 5 May 2016 | | 2.58 Cons. EPS | 2.57 EPS |
2025 © Marketlog. All Rights Reserved.
